STOCK TITAN
  1. Home
  2. Sec-filings
  3. DVAX
  4. [EFFECT] DYNAVAX TECHNOLOGIES CORP SEC Filing

[EFFECT] DYNAVAX TECHNOLOGIES CORP SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 13, 2026
Accession Number: 0001193125-26-044611
Submission Type: POS AM
CIK: 0001029142
Company Name: DYNAVAX TECHNOLOGIES CORP
File Number: 333-273674

Source: View Original Filing on SEC EDGAR

Stock DVAX logo
Dynavax Technolo

NASDAQ:DVAX

DVAX Rankings

#2295 Ranked by Market Cap
N/A Ranked by Dividends

DVAX Latest News

Dec 24, 2025
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Nov 19, 2025
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
Nov 5, 2025
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Nov 5, 2025
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Oct 22, 2025
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

DVAX Latest SEC Filings

Feb 11, 2026
[Form 4] DYNAVAX TECHNOLOGIES CORP Insider Trading Activity
Feb 11, 2026
[SCHEDULE 13G/A] DYNAVAX TECHNOLOGIES CORP Amended Passive Investment Disclosure
Feb 10, 2026
[Form 4] DYNAVAX TECHNOLOGIES CORP Insider Trading Activity
Feb 10, 2026
[Form 4] DYNAVAX TECHNOLOGIES CORP Insider Trading Activity
Feb 10, 2026
[Form 4] DYNAVAX TECHNOLOGIES CORP Insider Trading Activity

DVAX Stock Data

1.76B
112.69M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
EMERYVILLE